Physician profile
Kenneth R Case
NPI 1861485039
$2,213.11
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $651 · 2021: $942 · 2022: $263 · 2023: $20.26 · 2024: $50.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $488.02 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.54 | 2019-2022 | |
| Amarin Pharma, INC. | $193.87 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $178.33 | 2019-2024 | Crysvita |
| Astrazeneca Pharmaceuticals LP | $174.65 | 2019-2022 | |
| Lilly USA, LLC | $165.32 | 2020-2021 | |
| Abbvie INC. | $163.31 | 2021-2022 | |
| Esperion Therapeutics, INC. | $77.26 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.16 | 2020-2021 | |
| Glaxosmithkline, LLC. | $64.12 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $62.70 | 2019-2021 | |
| Pfizer INC. | $62.60 | 2020-2021 | |
| Eisai INC. | $53.30 | 2020-2021 | |
| Astellas Pharma US INC | $48.14 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $42.60 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $40.86 | 2019-2021 | |
| Allergan, INC. | $36.23 | 2020 | |
| Janssen Pharmaceuticals, INC | $31.11 | 2019-2020 | |
| Abbott Laboratories | $22.33 | 2021 | |
| Horizon Therapeutics Plc | $16.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.